A retrospective study on prescription pattern of drugs used in myocardial infarction in a South Indian Tertiary Care Hospital

---

Original Article

Author Details : Manohar Ganapathi Revankar, Vijaya Manohar Revankar, H. N. Gopalakrishna

Volume : 3, Issue : 3, Year : 2018

Article Page : 101-103

https://doi.org/10.18231/2456-9542.2018.0024

Suggest article by email

Get Permission

---

Abstract

Introduction: Angina pectoris, the primary symptom of ischemic heart disease, is caused by transient episodes of myocardial ischemia that are due to imbalance in the myocardial oxygen supply-demand relationship. Various drugs are prescribed which keeps changing during every decade. This study tries to know the current trends in prescription in myocardial infarction.
Material and Methods: About108 patients’ data were collected during the period year 2004-2008 admitted with acute myocardial infarction and data were entered in preformed proforma and were analysed by calculating percentage.
Statistical Analysis:Data were interpreted in terms of percentage.
Results: The percentage of prescription pattern of various classes of drugs was 91, 66.7, 63.9, 35.2, 31.5, 25, 15.7, 13.9, 12.9, 9.3 and 7.4 for Antiplatelet Agents, Antianginal drugs, Hypolipidemics, Beta receptor antagoist, Angiotensin Converting Enzyme Inhibitors (ACEI), Diuretics, Anticoagulants, Calcium Channel Blockers (CCBs), Angiotensin Receptor Blockers (ARBs), Fibrinolytics and Inotropic drugs respectively. Most of the patients received Aspirin as well as Clopidogrel.
Conclusion: Antiplatelet drugs was the most commonly prescribed and alpha blockers were prescribed least as evident from our study. 

Keywords:Myocardial Infarction, Prescription Pattern, Retrospective Study, Tertiary Care Hospital.

How to cite : Revankar M G, Revankar V M, Gopalakrishna H N, A retrospective study on prescription pattern of drugs used in myocardial infarction in a South Indian Tertiary Care Hospital. Indian J Clin Anat Physiol 2018;3(3):101-103

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.